|
|
|
|
 |
|
| Nutra Pharma is developing an innovative
pipeline of biopharmaceutical products |
|
|
|
|
|
|
|
|
|
|
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
|
|
|
Below you will find the most recent Nutra Pharma
press releases. To view press releases from previous
years, please visit the Archives.
November 17, 2008
Nutra Pharma Announces Provision of RPI-78M under Compassionate Release to Adrenomyeloneuropathy (AMN) Patients
August 14, 2008
Nutra Pharma Announces Initial Positive Safety Data from Clinical Study in Adrenomyeloneuropathy (AMN)
August 6, 2008
Nutra Pharma Announces Collaborative Agreement with Centers for Disease Control and Prevention (CDC)
August 1, 2008
August 2008 Shareholder Letter from Chairman and CEO Rik J. Deitsch
July 29, 2008
Nutra Pharma Announces Completion of Clinical Study in Adrenomyeloneuropathy (AMN)
May 19, 2008
Nutra Pharma Subsidiary, ReceptoPharm, Receives Approval to Begin Clinical Trials for the Treatment of Feline Leukemia Virus (FeLV)
April 14, 2008
Nutra Pharma Acquires Remaining Interest in Biopharmaceutical Drug Discovery Company - ReceptoPharm, Inc.
February 28, 2008
Nutra Pharma Announces Launch of Corporate Blog
February 25, 2008
Designer Diagnostics Begins Marketing First Ever Environmental Test Kit for the Detection of Nontuberculous Mycobacteria
August 13, 2007
Shareholder Letter from Chairman and CEO Rik J. Deitsch
|
|
|
| |
|
|
|
| |
|
| Click
Here for an Update on the Phase IIb Clinical Trial
Data. |
|
|
|
|
| |
|
|
|
|
